Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001410578-19-000263
Filing Date
2019-05-24
Accepted
2019-05-24 16:54:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 13047
2 g96354bci001.jpg GRAPHIC 2935
  Complete submission text file 0001410578-19-000263.txt   18177
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations